Depreciation, Depletion and Amortization of Vistagen Therapeutics, Inc. from 31 Mar 2015 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Vistagen Therapeutics, Inc. quarterly and annual Depreciation, Depletion and Amortization in USD history and change rate from 31 Mar 2015 to 30 Jun 2025.
  • Vistagen Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending 30 Jun 2025 was $40,000, a 18% increase year-over-year.
  • Vistagen Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2024 was $150,000, a 18% increase from 2023.
  • Vistagen Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $127,000, a 2.3% decline from 2022.
  • Vistagen Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $130,000.
Source SEC data
View on sec.gov
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)

Vistagen Therapeutics, Inc. Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $40,000 +$6,000 +18% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2026 Q1
Q2 2024 $34,000 +$2,000 +6.2% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2026 Q1
Q2 2023 $129,700 $32,000 -$300 -0.93% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2025 Q1
Q1 2023 $130,000 $33,800 01 Jan 2023 31 Mar 2023 10-K 11 Jun 2024 2024 FY
Q4 2022 $30,600 -$13,100 -30% 01 Oct 2022 31 Dec 2022 10-Q 07 Feb 2023 2022 Q3
Q3 2022 $33,300 -$3,400 -9.3% 01 Jul 2022 30 Sep 2022 10-Q 10 Nov 2022 2022 Q2
Q2 2022 $32,300 -$2,200 -6.4% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2024 Q1
Q4 2021 $155,200 $43,700 +$17,300 +66% 01 Oct 2021 31 Dec 2021 10-Q 07 Feb 2023 2022 Q3
Q3 2021 $137,900 $36,700 +$11,200 +44% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q2
Q2 2021 $126,700 $34,500 +$9,100 +36% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q1
Q1 2021 $117,600 $40,300 01 Jan 2021 31 Mar 2021 10-K 29 Jun 2021 2021 FY
Q4 2020 $26,400 01 Oct 2020 31 Dec 2020 10-Q 10 Feb 2022 2022 Q3
Q3 2020 $25,500 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2022 Q2
Q2 2020 $25,400 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q1

Vistagen Therapeutics, Inc. Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $150,000 +$23,000 +18% 01 Apr 2024 31 Mar 2025 10-K 17 Jun 2025 2025 FY
2023 $127,000 -$3,000 -2.3% 01 Apr 2023 31 Mar 2024 10-K 17 Jun 2025 2025 FY
2022 $130,000 01 Apr 2022 31 Mar 2023 10-K 11 Jun 2024 2024 FY
2020 $117,600 +$14,500 +14% 01 Apr 2020 31 Mar 2021 10-K 29 Jun 2021 2021 FY
2019 $103,100 +$11,900 +13% 01 Apr 2019 31 Mar 2020 10-K 29 Jun 2021 2021 FY
2018 $91,200 +$10,500 +13% 01 Apr 2018 31 Mar 2019 10-K 29 Jun 2020 2020 FY
2017 $80,700 +$25,800 +47% 01 Apr 2017 31 Mar 2018 10-K 25 Jun 2019 2019 FY
2016 $54,900 +$1,400 +2.6% 01 Apr 2016 31 Mar 2017 10-K 26 Jun 2018 2018 FY
2015 $53,500 -$5,600 -9.5% 01 Apr 2015 31 Mar 2016 10-K 29 Jun 2017 2017 FY
2014 $59,100 01 Apr 2014 31 Mar 2015 10-K 24 Jun 2016 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.